The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, Biomechanics, and Pain Intensity

Starting soon · Not applicable · Has a placebo group

Conditions studied: Gluteus Medius Muscle Strength, Lateral Hip Pain, Greater Trochanter Pain Syndrome, Gluteus Medius Tendinopathy, Gluteus Minimus Tendinopathy

In brief

We hypothesize that the addition of a unilateral neutral shoe insert combined with standard physical therapy (PT+SI) will have greater improvements in pain and function at 12 weeks and 6 months compared to physical therapy with sham inserts (PT+Sham) and physical therapy (PT) alone. In addition, we hypothesize that the addition of a neutral shoe insert in the involved limb will immediately improve biomechanics and pain with the single-leg stance test.

Key facts

Study ID

NCT06891001

Run by

Mayo Clinic

People needed

36

Starts

2027-01-01

Expected to finish

2029-01-01

Last updated by the study team

2026-01-22

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects with a history of unilateral hip pain lasting more than three months.
• Subjects with a VAS pain score of at least 3/10 localized to the lateral hip.
• Subjects with pain with palpation to lateral hip.
• Subjects with pain with either resisted hip abduction in relative adduction testing position and/or single leg stance test

You may not qualify if…

• Subjects wearing custom foot orthoses at the time of recruitment.
• Subjects who endorse current low back pain ≥ 3 on the NRS or lumbar radiculopathy
• Subjects with a medical history of spinal or lower limb surgery in the past 6 months.
• Subjects with a medical history of total joint replacement of hip, knee, or ankle on the symptomatic side
• Subjects who have had a corticosteroid injection at the hip within the last 12 months;
• Subjects demonstrating clinical signs and symptoms of intra-articular hip joint pathology with ≥ 3/10 groin pain including imaging confirmed significant labral tearing requiring surgery or osteoarthritis > 2 (mild) on Kellgren-Lawrence score on radiographs.
• Subjects previously diagnosed with systemic inflammatory conditions; active cancer/malignant tumors; or neurological conditions that would affect gait
• Subjects who have had physical therapy within the past 3 months for hip pain
• If subjects are unable to commit to 12 weeks of therapy with one supervised session weekly
• Subjects who have the intention to perform treatments outside of this study including, but not limited to, dry needling or acupuncture, extracorporeal shockwave, therapeutic ultrasound, a TENEX procedure, medication injection therapies, platelet-rich plasma injections, stem cell injections, and surgery.

Where it is running

• Mayo Clinic — Glendale, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.